SCHEMBL2185533

SCHEMBL2185533

O=C(Oc1ccc2c(Oc3ccc(OCCC4CCCCN4)cc3)c(-c3ccc(F)c(F)c3F)ccc2c1)C(F)(F)F

nearest known ligand 0.41

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 11/20 0.41
ESR2 Q92731 11/20 0.41
CHEK2 O96017 1/20 0.39
LTA4H P09960 3/20 0.37
HRH4 Q9H3N8 1/20 0.36
AURKB Q96GD4 1/20 0.36
SCN9A Q15858 1/20 0.35
SSTR2 P30874 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6233957 0.84 ESR1 (0.44) ESR1ESR2CHEK2LTA4HHRH4
SCHEMBL1359340 0.82 ESR1 (0.61) ESR1ESR2
Hydrochloric Acid SCHEMBL6004572 0.80 ESR1 (0.51) ESR1ESR2SSTR2
Hydrochloric Acid SCHEMBL6005550 0.79 ESR1 (0.54) ESR1ESR2LTA4H
Hydrochloric Acid SCHEMBL6004711 0.78 ESR1 (0.56) ESR1ESR2SSTR2
Hydrochloric Acid SCHEMBL6004577 0.78 ESR1 (0.50) ESR1ESR2LTA4H
Hydrochloric Acid SCHEMBL6005706 0.78 ESR1 (0.54) ESR1ESR2LTA4H
Hydrochloric Acid SCHEMBL6003405 0.77 ESR1 (0.66) ESR1ESR2CHEK2SSTR2
SCHEMBL6005679 0.77 CHEK2 (0.44) ESR1ESR2CHEK2AURKBSSTR2
SCHEMBL6235937 0.76 ESR1 (0.57) ESR1ESR2LTA4HSSTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2342189-A2 SELECTIVE ESTROGEN RECEPTOR MODULATOR FOR THE TREATMENT OF OSTEOARTHRITIS ELI LILLY AND COMPANY (US) 2011-07-13 EP disclosed
WO-2010036497-A2 SELECTIVE ESTROGEN RECEPTOR MODULATOR ELI LILLY AND COMPANY (US) 2010-04-01 WO disclosed
EP-1709021-A1 SELECTIVE ESTROGEN RECEPTOR MODULATORS FOR THE TREATMENT OF VASOMOTOR SYMPTOMS ELI LILLY AND COMPANY (US) 2006-10-11 EP disclosed
WO-2005073204-A1 SELECTIVE ESTROGEN RECEPTOR MODULATORS FOR THE TREATMENT OF VASOMOTOR SYMPTOMS ELI LILLY AND COMPANY (US) 2005-08-11 WO disclosed